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provided it is propeObjectives: HIV-1 replication depends on the state of cell activation and division. It is
established that SAMHD1 restricts HIV-1 infection of resting CD4þ T cells. The
modulation of SAMHD1 expression during T-cell activation and proliferation, however,
remains unclear, as well as a role for SAMHD1 during HIV-1 pathogenesis.
Methods: SAMHD1 expression was assessed in CD4þ T cells after their activation and
in-vitro HIV-1 infection. We performed phenotype analyzes using flow cytometry on
CD4þ T cells from peripheral blood and lymph nodes from cohorts of HIV-1-infected
individuals under antiretroviral treatment or not, and controls.
Results: We show that SAMHD1 expression decreased during CD4þ T-cell prolifer-
ation in association with an increased susceptibility to in-vitro HIV-1 infection.
Additionally, circulating memory CD4þ T cells are enriched in cells with low levels
of SAMHD1. These SAMHD1low cells are highly differentiated, exhibit a large pro-
portion of Ki67þ cycling cells and are enriched in T-helper 17 cells. Importantly,
memory SAMHD1low cells were depleted from peripheral blood of HIV-infected
individuals. We also found that follicular helper T cells present in secondary lymphoid
organs lacked the expression of SAMHD1, which was accompanied by a higher
susceptibility to HIV-1 infection in vitro.
Conclusion: We demonstrate that SAMHD1 expression is decreased during CD4þ
T-cell activation and proliferation. Also, CD4þ T-cell subsets known to be more
susceptible to HIV-1 infection, for example, T-helper 17 and follicular helper T cells,
display lower levels of SAMHD1. These results pin point a role for SAMHD1 expression
in HIV-1 infection and the concomitant depletion of CD4þ T cells.
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520 AIDS 2015, Vol 29 No 5IntroductionThe infection of CD4þ T cells by HIV-1 relies on the
activation state of the cell [1,2]. It has long been known
that activated cells are more prone to HIV-1 infection
than quiescent CD4þ T cells [3]. SAMHD1 restricts
productive HIV-1 infection in dendritic cells, myeloid
cells [4,5] and resting CD4þ T cells [6,7]. Several
mechanisms have been proposed for SAMHD1 blocking
of HIV-1 infection. Indeed, SAMHD1 is a deoxynucleo-
side triphosphates (dNTPs) hydrolase and its expression
decreases the intracellular dNTP pool thus blocking the
reverse transcription [6–8]. Phosphorylation of
SAMHD1, however, has been shown to inhibit the
restriction activity of SAMHD1 [9–11], independently of
the dNTPase capacity. The ribonuclease activity of
SAMHD1 was recently reported to be crucial for HIV-1
restriction [12]. Of importance, several T-cell lines [4–6]
as well as peripheral blood mononuclear cells (PBMCs)
from patients suffering T-cell lymphoproliferative disease
[13] display low levels of SAMHD1, illustrating the
possible modulation of SAMHD1 expression.
Although the mechanisms of SAMHD1 restriction have
been the subject of intense investigation, it remains to be
determined whether SAMHD1 plays a role in HIV-1
pathogenesis. In the present article, we evaluated the
regulation of SAMHD1 expression during CD4þ T-cell
activation and found that SAMHD1 levels decrease with
cell proliferation. Importantly, the activation-induced
SAMHD1 decrease was associated with higher suscepti-
bility to HIV-1 infection in vitro. We found that peripheral
memory CD4þ T cells comprise a subset of cells
expressing low levels of SAMHD1. Those CD4þSAMH-
SAMHD1low T cells are highly differentiated, enriched in
cycling cells and are significantly decreased in HIV-
infected individuals as compared with controls. In
addition, peripheral T-helper 17 (Th17), as well as
lymph nodes follicular helper T (Tfh) cells, two CD4þ
T-cell subsets highly susceptible to HIV-1 infection,
displayed the lowest expression of SAMHD1. Our results
uncover that the regulation of SAMHD1 expression
during T-cell activation and differentiation participate to
the susceptibility of CD4þ T cells to HIV-1 infection.Methods
Patient information
Ethical committee approval and written informed
consent from all individuals or their parents, in
accordance with the Declaration of Helsinki, were
obtained prior to study initiation.
Peripheral blood was collected from healthy controls
(n¼ 19) and HIV-1-infected individuals (n¼ 35) (Table,
Supplemental Digital Content 1, http://links.lww.com/QAD/A646). Among the HIV-1-infected patients, 23
were receiving antiretroviral therapy (ART) [median
(range) CD4þ T-cell count: 522 (129–1080) cells/ml;
HIV-1 RNA: <20 (0–74042) copies/ml], six were
either naive to treatment or under treatment inter-
ruption [median (range) CD4þ T-cell count: 255
(145–805) cells/ml; HIV-1 RNA: 54047 (982–
158169) copies/ml], and six individuals were elite con-
trollers [median (range) CD4þ T-cell count: 900 (737–
1483) cells/ml; HIV-1 RNA: 94 (0–308) copies/ml].
Human peripheral blood and cord blood (n¼ 5) were
obtained from Etablissement Franc¸ais du Sang. PBMCs
were isolated by Ficoll gradient centrifugation (PAA
Laboratories, Velizy, France) and then either processed
immediately or stored frozen until required for analysis.
Tonsils (n¼ 28) were obtained from children undergoing
tonsillectomy at the Necker Hospital, Paris. Mechanical
tissue disruption and 70mm filtration were used to isolate
single-cell suspension.
Surgically removed axillary lymph nodes from HIV-1-
infected individuals (n¼ 6, CD4þ T-cell count: 318
(122–573) cells/ml; HIV-1 RNA <50 copies/ml] were
obtained from the University Medical Center Eppendorf.
HIV-negative lymph node samples (n¼ 6) were obtained
from organ donors, who tested negative for HIV-1 and
had no chronic infections, through National Disease
Research Interchange, University Medical Center
Eppendorf, and Columbia Center for Translational
Immunology (Table, Supplemental Digital Content 2,
http://links.lww.com/QAD/A646).
Ex-vivo T-cell phenotype
Multicolor flow cytometry was performed on fresh
PBMCs and frozen LNMCs. T-cell subpopulations were
determined using the different combinations of the
following fluorochrome-conjugated antibodies: Pacific
Blue, PE-Cy7 or Alexa-Fluor 700anti-CD3, PerCP or
Alexa-Fluor 700 anti-CD4, PE anti-CD27, PE-Cy7 anti-
CCR7, PE-CF594 anti-CD45RO, Alexa-Fluor 488
anti-CXCR5, Alexa-Fluor 647 anti-CCR4, PE anti-
CXCR3, PE-Cy7 anti-CCR6 (Becton Dickinson
Biosciences, Pont de Claix (Le), France). Vioblue anti-
CD3, APC-Vio770 anti-CD4, APC-Vio770 anti-
CD45RO, APC anti-CD28 (Milteniy Biotech, Paris,
France). Brillant Violet 421 anti-CD279 (Biolegend,
London, UK).
Intracellular staining was carried out using the FoxP3
permeabilization solution kit according to the manu-
facturer’s instructions (eBioscience, Paris, France)
together with PE Ki67, PE anti-Bcl-6 (BD Pharmingen)
or PE anti-FoxP3 (Biolegend), and Alexa-Fluor 488 anti-
SAMHD1 (a gift from O. Schwartz) or rabbit anti-
SAMHD1 (Euromedex, Souffelweyersheim, France)
followed by Alexa-Fluor 647 antirabbit antibody
(Invitrogen, Life Technologies, Saint Auben, France).
SAMHD1 expression during HIV-1 infection Ruffin et al. 521Dead cells were excluded using the Live/Death Vivid
detection kit labeled with an aqua dye (Invitrogen).
Fluorescence intensities were measured with an LSR II
flow cytometer (Becton Dickinson) and analyzed using
FlowJo version 7.6.5 (Tree Star Inc., Ashland, Oregon,
USA).
In vitro T-cell proliferation
Purified CD4þ T-lymphocytes from healthy individuals
were separated from PBMCs using the CD4þ T-cell
Isolation Kit II (Miltenyi Biotech) and stained with either
0.25mmol CFSE or 0.5mmol Cell Trace Violet
(Invitrogen). Purified CD4þ T cells (1 106) were
cultured in RPMI-1640 (Life Technologies) containing
L-glutamine, 10% fetal calf serum and antibiotics
(penicillin and streptomycin) on a precoated 48-well
plate with anti-CD3 (2mg/ml) and anti-CD28 (2mg/
ml) (Beckman Coulter, Villepinte, France). After 72 h,
cells were stained with Vioblue anti-CD3, APC-Vio770
anti-CD4 (Miltenyi Biotech) together with the Aqua
Live/Death Vivid detection kit (Invitrogen). Samples
were fixed and permeabilized using the FoxP3 permea-
bilization kit (eBioscience) and further stained with
either Alexa Fluor 488 anti-SAMHD1 (a gift from O.
Schwartz) or rabbit anti-SAMHD1 (Euromedex) fol-
lowed by Alexa-Fluor 647 antirabbit antibody (Invitro-
gen). Fluorescence intensities were measured as
described previously. Alternatively, CFSE-labeled cells
were sorted according to CFSE fluorescence intensity
using a MoFlo Legacy (Beckman Coulter) for mRNA
quantification.
In-vitro HIV-1 infection
Purified CD4þT cells from PBMCs were separated using
the CD4þ T-cell Isolation Kit II (Miltenyi Biotech) and
stained with Cell Trace Violet (Invitrogen). CD4þ T cells
(1 106) were cultured in RPMI-1640 containing L-
glutamine, 10% fetal calf serum and antibiotics (penicillin
and streptomycin) on a precoated 48-well plate with anti-
CD3 (2mg/ml) and anti-CD28 (2mg/ml) (Beckman
Coulter). After 72 h, cells were incubated for 2 h in the
presence of 100 ng NL4.3 HIV-1 lab strain virus. We used
a wild-type HIV-1, NL4.3 strain, pseudotyped with
Vesicular stomatitis virus G glycoprotein (VSV-G)
produced in HEK 293T cells as described previously
[14]. After washing in RPMI medium, cells were further
cultured for 2–3 days on a precoated 48-well plate with
anti-CD3 (2mg/ml) and anti-CD28 (2mg/ml). The
reverse transcriptase inhibitor nevirapine (used at a final
concentration of 25 nmol) was from the NIH AIDS
Reagents Program. Cells were stained with aqua Vivid
and fixed in PFA 4% in PBS for 15 min before a 20-min
incubation in PBS containing 0.5% Triton X-100
(Sigma-Aldrich, St Quentin Fallavier, France) for
permeabilization. Alexa-Fluor 488 anti-SAMHD1 and
RD1 KC57 (antip24, Beckman Coulter) were used for
intracellular staining as described above.Alternatively, purified CD4þ T cells from tonsils were
separated using the CD4þT-cell Isolation Kit II (Miltenyi
Biotech) and stained with Cell Trace Violet (Invitrogen).
Cells were additionally stained with anti-CD3, anti-CD4,
anti-CXCR5 and anti-PD-1, and sorted using a MoFlo
Legacy. Sorted CD4þ T cells were infected and then
incubated for 2 h in the presence of 100 ng NL4.3 HIV-1
lab strain virus as described above. Cells were then
cultured for 3 days in RPMI-1640 containing L-
glutamine, 10% fetal calf serum and antibiotics (penicillin,
streptomycin and gentamicin) for 3 days on 96-well plate
previously coated with anti-CD3/CD28 (2mg/ml each).
The final steps were performed as described above.
Statistical analyzes
Wilcoxon matched-pairs signed rank test was used to
analyze the difference in SAMHD1 expression in
lymphocytes. Two-way analysis of variance (ANOVA)
followed by Bonferroni posttests were performed on data
of SAMHD1 expression in CD4þ T-cell subpopulations
as well as Th cell population repartitions and Ki67
expression between SAMHD1þ and SAMHD1low CD4þ
T cells. One-way ANOVA followed by Dunn’s multiple
comparison tests were used for analyses of SAMHD1
expression during CD4þ T-cell proliferation and the
levels of p24 expression after in-vitro infection.
Correlations were evaluated using the Spearman’s rank
correlation test. A P value less than 0.05 was considered
significant. Statistical analyses and graphic representation
of the results were performed using Prism (v.5.0b;
GraphPad, San Diego, California, USA)Results
TCR triggering induces the decreased expression
of SAMHD1 in CD4R T cells
Resting CD4þ T cells express SAMHD1, preventing
their infection by HIV-1 [6,7]. The activation of CD4þT
cells is thought not to modify the levels of SAMHD1
expression [6,10]. We used anti-CD3 and anti-CD28
antibodies to activate CD4þ T cells and establish whether
the expression of SAMHD1 can be modulated during T-
cell proliferation. As shown in Fig. 1a, the levels of
SAMHD1 gradually decreased with CD4þ T-cell
divisions to reach a plateau after four cycles of division.
The decrease in protein expression was also associated
with decreased SAMHD1-mRNA in proliferating-cells
(Fig. 1b). These results are in contrast to previous
publication using different activation [6] and/or measur-
ing SAMHD1 expression on the bulk of CD4þ T cells
[6,10]. When using phytohemagglutinin and interleukin-
2 (PHA/interleukin-2), proliferating CD4þ T cells
similarly decreased their expression of SAMHD1 (Figure,
Supplemental Digital Content 3, http://links.lww.com/
QAD/A646). We then confirmed that cells expressing
lower levels of SAMHD1 were more susceptible to HIV-1
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Fig. 1. SAMHD1 expression is decreased during T-cell proliferation and is associated with higher susceptibility to HIV-1
infection. (a) Purified CD4þ T cells were stained with Cell Trace Violet (n¼14) and cultured in the presence of coated anti-CD3
(2mg/ml) and anti-CD28 (2mg/ml) mAbs. At day 5/6, CD3þCD4þ T cells were then stained for SAMHD1. Representative dot-plot
of SAMHD1 and Cell Trace staining (left panel) and SAMHD1 expression (right panel) measured by mean fluorescent intensity
(MFI) in cells gated according to the number of cell division. Data represent mean with SEM. (b) CFSE-labeled CD4þ T cells (n¼3)
were sorted according to CFSE dilution after 5 days of culture in the presence of coated anti-CD3 and anti-CD28mAbs. qPCRwere
then performed for SAMHD1 gene expression on CFSE low, CFSEmedium and CFSEhigh fractions. Data represent fold-change in
SAMHD1 gene expression in sorted populations (mean with SEM). P<0.05, P<0.01, one-way analysis of variance tests
followed by Dunn’s multiple comparison test. (c) Purified CD4þ T cells were stained with Cell Trace Violet and cultured in the
presence of anti-CD3/CD28 (2mg/ml) for 72 h. Cells were then infected for 2 hwithHIV-1 (NL4.3 strain, 100ng/ml) in the presence
or not of nevirapine (NVP), a retrotranscriptase inhibitor. SAMHD1 and p24 (KC57) expression were assessed 48h postinfection.
Dot-plots represent Cell Trace and p24 expression. (d) SAMHD1 expression (red bars) as measured by mean fluorescence intensity
(MFI) and percentages of p24 positive cells (blue bars) among proliferating CD4þ T-cells gated by cell division. (e) Correlation of
SAMHD1MFI and percentages of p24 positive cells on proliferating CD4þ T cells gated by cell division. Data are representative of
one experiment out of two.infection in vitro. CD4þ T cells were activated for 72 h
with anti-CD3/CD28 then infected for 2 h with the
HIV-1 NL4.3-strain. Despite similar levels of phos-
phorylated SAMHD1 (Figure, Supplemental Digital
Content 4, http://links.lww.com/QAD/A646), prolif-
erating cells showed the highest levels of intracellular p24(Fig. 1c and d). Notably, there was an inverse correlation
between the levels of SAMHD1 and the percentages of
p24þ cells (P¼ 0.016; Fig. 1d and e). Thus, the activation
of CD4þ T cells induces a downregulation of SAMHD1
expression in dividing CD4þ T cells that associates with
an increased susceptibility to HIV-1 infection in vitro.
SAMHD1 expression during HIV-1 infection Ruffin et al. 523CD4R T cells expressing low SAMHD1 are
enriched in cycling cells and are depleted during
HIV-1 infection
The hallmark of HIV-1 infection is the chronic immune
activation [15]. To evaluate whether SAMHD1 expres-
sion was also modulated during HIV-1 infection, we
assessed its expression in different subsets of CD4þT cells.
As shown previously [6,7], although SAMHD1 was
absent in a proportion of lymphocytes (43 19% of non-
T cells), it was expressed by most CD3þ T cells
(94 0.7%) (Figure, Supplemental Digital Content 5,
http://links.lww.com/QAD/A646). Among CD4þ
T cells, we observed that a subset of memory cells
displayed low levels of SAMHD1 (Fig. 2a). These
SAMHD1low cells were preferentially in the memory
compartment of adult PBMCs and could not be
identified within cord blood (Fig. 2a). Importantly,
ART-treated patients (n¼ 23), non-ART-treated patients
(n¼ 6) and elite-controllers (n¼ 6) showed 4.14 2.95,
5.84 3.01 and 5.29 3.3% of SAMHD1low cells in the
blood CD4þ T-cell memory compartment, respectively,
values significantly lower than those of HIV-negative
controls (n¼ 13, 10.86 5.83%) (data not shown).
Deconvolution of the CD4þ T-cell compartment
revealed lower proportions of SAMHD1low cells in
transitional memory TTM (CCR7
CD27þCD45ROþ/
RA), effector memory TEM (CCR7
CD27
CD45ROþ/RA) and terminally differentiated TTD
(CCR7CD27CD45RO/RAþ) in HIV-positive as
compared with HIV-negative individuals (Fig. 2b and c).
In contrast, HIV-positive and HIV-negative individuals
showed similar numbers of SAMHD1low cells within
naive (CCR7þCD27þCD45RO/RAþ) and central-
memory TCM (CCR7
þCD27þCD45ROþ/RA) CD4þ
T cells (Fig. 2c). Together these results reveal the presence
of a highly differentiated SAMHD1low CD4þT-cell subset
in peripheral blood that is decreased in HIV-infected
patients.
To evaluate whether SAMHD1lowCD4þ T cells are
activated in vivo, we measured Ki67 expression, as well as
markers of T-cell activation on PBMCs from HIV-
negative and HIV-positive individuals. As shown in
Fig. 2d and e, SAMHD1lowCD4þ T cells display
high levels of Ki67 (P< 0.001 as compared with
SAMHD1þCD4þ T cells), thereby indicating their
cycling status. SAMHD1lowCD4þ T cells from non-
treated HIV-infected individuals exhibited the highest
proportion of Ki67þ cells (37.20 27.56%) as compared
with ART-treated individuals, elite controllers and healthy
controls that showed 21.48 19.71, 12.87 5.49 and
12.23 9.93%, respectively (P< 0.01). Gating strategies
for representative patients in each group are shown in
Supplemental Digital Content 6, http://links.lww.com/
QAD/A646. In addition, SAMHD1lowCD4þ T cells
showed significantly higher levels of PD-1, CD38
and HLA-DR expression than SAMHD1þCD4þ
T cells (Figure, Supplemental Digital Content 7,http://links.lww.com/QAD/A646), confirming their
activated state. Altogether, our data indicate that CD4þ
T cells may be losing SAMHD1 expression during their
differentiation and proliferation after antigen encounter
in vivo.
The blood SAMHD1low CD4R T-cell
compartment decrease is restricted to T-helper
17 cells
As differential susceptibility to HIV-1 infection has
been described for CD4þ T-cell subsets [16–19],
we further examined the expression of SAMHD1
in Th1 (CD45ROþCXCR3þCCR4CCR6), Th2
(CD45ROþCXCR3CCR4þCCR6), Th17 (CD45
ROþCXCR3CCR4þCCR6þ) [20], Tregs (CD45
ROþCD25þCD127low) [21] and Tfh-like (CXCR
5þPD1þ) cells [22,23] (Fig. 3a). Proportions of SAMH-
D1low cells were comparable in HIV-negative and HIV-
positive individuals in all subsets except Th17 (Fig. 3b
and c). Indeed, 12.22 3.01% of Th17 cells expressed
low levels of SAMHD1 in HIV-negative controls
as compared with 6.42 4.39% in HIVþcARTþ
(P< 0.001), 5.50 4.30% in HIVþcART (P< 0.01)
and 8.56 2.20% in HIVþEC (P> 0.05) individuals
(Fig. 3c). Moreover, Th17 cells were enriched in the
SAMHD1low compartment compared with SAMHD1þ,
and there was a significant decrease of SAMHD1low cells
among Th17 in HIVþ individuals [18.38 6.37% in
HIV vs. 10.66 5.77% in HIVþcARTþ (P< 0.001),
7.11 6.62% in HIVþcART (P< 0.001) and
14.19 3.41% in HIVþEC (P> 0.05); Fig. 3d]. The
proportions of other Th subsets within SAMHD1low cells
did not vary noticeably between our groups of HIV-
negative and HIV-positive individuals, except for the Th2
population. Unlike for Th17 cells, however, we found
lower proportions of Th2 cells in both SAMHD1low and
SAMHD1þ compartments in HIV-infected individuals as
compared with controls.
Consistent with their preferential depletion during HIV-
1 infection [16–19], our results suggest that higher
susceptibility of Th17 cells to HIV-1 infection may be
linked to a lower expression of SAMHD1.
Follicular helper T cells from secondary
lymphoid organs express low levels of SAMHD1
and are highly susceptible to HIV infection
Recent data indicated that CXCR5þPD1hi Tfh cells in
the lymph nodes were more susceptible to HIV-1
infection [24,25]. We investigated the presence of
SAMHD1lowCD4þ T cells in lymph nodes from both
HIV-negative and HIV-positive cART-treated individuals
(Fig. 4a). Flow cytometry analyses revealed that
CXCR5þPD1hi Tfh cells were mostly SAMHD1low
(Fig. 4a and b). The high levels of the transcription factor
Bcl-6 in CXCR5þPD1hiCD4þ T cells from both groups
further demonstrate that these cells are indeed Tfh cells
(Fig. 4c). The frequency of CXCR5þPD1hi Tfh cells was
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Fig. 2. Low SAMHD1 expression on differentiated and cycling CD4R T cells ex vivo. Cord blood (n¼5) and peripheral blood
mononuclear cells (PBMCs) from HIV-1 negative (HIV, n¼13) or HIV-1-infected individuals treated (HIVþ cARTþ, n¼23),
nontreated (HIVþ cART, n¼6) or elite controllers (HIVþ EC, n¼6) were stainedwith anti-CD3, anti-CD4, anti-CD45ROor anti-
CD45RA, anti-CCR7, anti-CD27, anti-CD28 and anti-SAMHD1. (a) Representative dot-plots of SAMHD1 and CD45RO
expression in CD4þ T cells from adult PBMCs and cord blood. (b) Gating strategy of CD4þ T-cell subpopulations into naive
(TN: CD45RO
CCR7þCD27þ), central memory (TCM: CD45RO
þCCR7þCD27þ), transitional memory (TTM: CD45RO
þ
CCR7CD27þ), effector memory (TEM: CD45RO
þCCR7CD27þ) and terminally differentiated (TTD: CD45RO
CCR7CD27).
). (c) Percentages of SAMHD1low cells among naive (TN), central memory (TCM), transitional memory (TTM), effector memory
(TEM), and terminally differentiated (TTD) CD4
þ T cells. (d) Representative dot-plots of SAMHD1 and CD45RO expression among
live CD4þ T cells showing the gating of SAMHD1þ and SAMHD1low cells (left panel), and representative histogram of Ki67
expression in gated SAMHD1þ and SAMHD1low cells from PBMCs isolated from an nontreated HIV-1 infected individuals. (e)
Percentages of Ki67þ cells among SAMHD1þ and SAMHD1low CD4þ T cells from PBMCs isolated from healthy individuals
(n¼13) and HIV-1-infected individuals treated (HIVþ cARTþ, n¼18), nontreated (HIVþ cART, n¼ 5) or elites controllers
(HIVþ EC, n¼6). Data represent median with 25th–75th interquartile range with means displayed as þ. P< 0.05, P<0.01,
P<0.001, two-way analysis of variance tests followed by Bonferroni posttests.
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Fig. 3. SAMHD1low T-helper 17 cells are preferentially depleted during HIV-1 infection. Fresh peripheral blood mononuclear
cells fromHIV-1-negative (HIV, n¼13) or HIV-1-infected individuals treated (cARTþHIVþ, n¼17), nontreated (cARTHIVþ,
n¼5) or elite controllers (HIVþ EC, n¼6) were stained with anti-CD3, anti-CD4, anti-CD45RO, anti-CXCR3, anti-CCR4, anti-
CCR6 or anti-CD127 and anti-CD25 or anti-CXCR5 and anti-PD1, and anti-SAMHD1. Aqua Vivid was included in the procedure
to remove dead cells from the analysis. (a) Gating strategy for memory T helper 1 (Th1: CD45ROþCXCR3þCCR4CCR6), Th1/
Th17 (CD45ROþCXCR3þCCR4CCR6þ), Th2 (CD45ROþCXCR3CCR4þCCR6), Th17 (CD45ROþCXCR3CCR4þCCR6þ),
Treg (CD45ROþCD127lowCD25hi) and Tfh-like (CD45ROþCXCR5þPD1þ) CD4þ T cells. (b) Representative dot-plots of SAMHD1
expression within the Th17 subset gated as in (a) from anHIV-1 negative (HIV-), HIV-1 infected individuals treated (cARTþHIVþ),
nontreated (cART- HIVþ) and elite-controllers (HIVþ EC). (c) Percentages of SAMHD1low cells among Th17, Th1/17, Th1, Th2,
Treg and Tfh-like CD4þ T-cells. (d) Percentages of Th17, Th1/17, Th1, Th2, Treg and follicular helper T (Tfh) like cells among gated
SAMHD1þ and SAMHD1low CD4þ T cells. Data represent median with 25th–75th interquartile range with means displayed asþ.
P<0.05, P< 0.01 and P< 0.001, two-way analysis of variance tests followed by Bonferroni posttests.
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Fig. 4. Follicular helper T CD4R T cells from lymph nodes express low levels of SAMHD1. LNMCs fromHIV-negative (n¼6) and
ART-treated HIV-1-infected individuals (n¼6) were stained for CD3, CD4, CXCR5, PD1, Bcl-6, SAMHD1 and Vivid. (a)
Representative dotplots displaying CD45RO and SAMHD1 expression with the gating strategy for SAMHD1low cells on gated
live CD4þ T lymphocytes. Left panel display the percentages of SAMHD1low cells among CD45ROþCD4þ T cells in HIV negative
and treated-HIV-positive individuals. (b) Representative dot plots displaying PD1 and CXCR5 expression with gating strategy used.
(c) Representative histogram showing Bcl-6 expression (left panel), and mean fluorescence intensity of Bcl-6 expression (right
panel) in gated CXCR5PD1, CXCR5þPD1int, CXCR5PD1þ and CXCR5hiPD1hi CD4þ T-cell subpopulations. (d) Representative
histogram showing SAMHD1 expression (left panel), and percentages of SAMHD1low cells (right panel) in gated CXCR5PD1,
CXCR5þPD1int, CXCR5PD1þ and CXCR5hiPD1hi CD4þ T-cell subpopulations.not significantly different between treated-HIV-positive
and HIV-negative individuals (data not shown), as
described earlier [24,25]. Tfh from HIV-1-infected
individuals produced higher levels of interleukin-21
and lower interleukin-17 as compared with HIV-negative
individuals, whereas no difference in interferon-g, tumor
necrosis factor-a and interleukin-2 production was
found (Figure, Supplemental Digital Content 8, http://
links.lww.com/QAD/A646).For further analysis, due to the scarcity of lymph nodes
samples from healthy individuals, we used tonsils from
HIV-negative individuals undergoing tonsillectomy.
Tonsilar Tfh cells (CXCR5þPD1hiBcl-6þ), similar to
Tfh from lymph nodes, expressed lower levels of
SAMHD1 at both protein and mRNA levels when
compared with CXCR5PD1, CXCR5þPD1int and
CXCR5PD1þ (Fig. 5a–c, and Figure, Supplemental
Digital Content 9, http://links.lww.com/QAD/A646).
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Fig. 5. Follicular helper T CD4R T cells from tonsils display similar phenotype as from lymph nodes and are highly susceptible to
HIV-1 infection in vitro.Cells weremechanically isolated from human tonsils (n¼10) and stained for CXCR5, PD1, SAMHD1 and
Bcl-6. (a) Representative dot-plot of CXCR5 and PD1 expression on gated live CD4þCD3þ lymphocytes from tonsils showing the
gating strategy used for the analysis and the sorting of the cells. (b) Representative histogram and individual levels of Bcl-6
expression measured as mean fluorescence intensity (MFI) on gated populations. (c) Representative histogram and individual
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expression and infected with 100 ng NL4.3Nevirapine for 2 h and cultured on anti-CD3 and anti-CD28 mAbs (2mg/ml)
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representative of one out of three independent experiments. (e) Individual-fold differences in HIV-1 infection of tonsilar sorted
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1-way analysis of variance tests followed by Dunn’s multiple comparison test.Moreover, CXCR5þPD1hiBcl-6þSAMHD1low cells
were Foxp3-negative, ruling out their regulatory Tfh
phenotype and function [26]. They also expressed low
levels of PRDM1/Blimp-1, the transcription factor that
is mutually antagonistic with Bcl-6 [27]. CXCR5þPD1hi
cells expressed low levels of CD26, high levels of CD38,CD161, CD278 and CD152, and are enriched in Ki67þ
cells (Figure, Supplemental Digital Content 10a, http://
links.lww.com/QAD/A646), confirming their activated
phenotype, in line with their function in the germinal
center [28]. We have also found Tfh cells to express high
and intermediate levels of CXCR4 and CCR5,
528 AIDS 2015, Vol 29 No 5respectively (Figure, Supplemental Digital Content 10B,
http://links.lww.com/QAD/A646). In addition and
in line with recent studies [24,29,30], sorted
CXCR5þPD1hi cells did not proliferate to the same
extent as CXCR5PD1, CXCR5þPD1int and
CXCR5PD1þ. (Figure, Supplemental Digital Content
11, http://links.lww.com/QAD/A646).
To determine whether Tfh cells are more sensitive to
HIV-1 infection, we infected in-vitro-sorted subsets with
the HIV-1 NL4.3-strain. Data illustrated in Fig. 5d and
e show that in-vitro-infected CXCR5þPD1hi Tfh
cells have higher levels of intracellular p24 than
CXCR5PD1 and CXCR5þPD1int cells. Taken
together these results suggest that low SAMHD1
expression in CXCR5þPD1hi Tfh cells might explain
their increased susceptibility to HIV-1.Discussion
Although SAMHD1 restriction activity toward HIV-1
infection is well established in vitro [5,6,12], its
importance in the course of HIV-1 pathogenesis remains
largely unknown. We demonstrate here that SAMHD1
expression is regulated after T-cell activation and that
SAMHD1lowCD4þ T cells are preferentially susceptible
to HIV-1 infection. Our results enlighten a possible role
of SAMHD1 in the CD4þ T-cell depletion occurring in
HIV-1-infected individuals.
We show that during CD4þ T-cell division, there is a
downregulation of SAMHD1 at both mRNA and protein
levels. Importantly, the decreased SAMHD1 expression
during CD4þ T-cell proliferation correlated with an
increased HIV-1 infection in vitro. Therefore, whereas
SAMHD1 phosphorylation is an important determinant
for HIV-1 restriction [9–12], we show that the protein
expression, downregulated after T-cell activation, lead
also to an increased susceptibility of CD4þT cells to HIV-
1 infection.
The mechanisms of CD4þT-cell depletion during HIV-1
pathogenesis are multiple and remain a field of constant
scientific investigation. It has been shown that the best
correlate for CD4þ T-cell decline in HIV-1-infected
individuals is the level of immune activation [31–33]. As
SAMHD1 expression is modulated by CD4þ T-cell
activation in vitro, we wondered if similar mechanisms
could take place in vivo. By measuring SAMHD1
expression in peripheral CD4þ T cells, we reveal that
a subset of memory cells displays low levels of SAMHD1
when compared with the majority of CD4þ T cells.
SAMHD1lowCD4þ T cells are enriched in differentiated
effector CD4þ T cells, the primary targets of HIV-1 [34].
In line with this, we found SAMHD1lowCD4þ T cells to
be depleted in HIV-1-infected individuals, as comparedwith healthy controls, a finding consistent with
SAMHD1 being a restriction factor for HIV-1 infection.
Of note, we did not observe any differential expression of
SAMHD1 between our different groups of HIV-infected
individuals, in contrast to a recent study showing an
increased SAMHD1-mRNA expression in EC mono-
nuclear cells [35]. Our results strongly suggest that
SAMHD1lowCD4þ T cells are depleted in HIV-1-
infected individuals and are not recovered after ART
initiation.
Notably, we found that peripheral SAMHD1lowCD4þ
T cells express higher levels of Ki67 ex vivo, indicating
that they are enriched in cycling cells. Memory
SAMHD1lowCD4þ T cells also displayed higher expres-
sion of the activation markers CD38, HLA-DR and PD-
1 as compared with SAMHD1þ cells. These results
confirm that T-cell activation in vivo can also induce
SAMHD1 downregulation. Thus, we uncover a new
mechanism that may account for the high susceptibility
toward HIV-1 infection of rapidly proliferating effector/
memory CD4þ T cells. It might also be of interest to
understand the molecular determinants modulating
SAMHD1 expression. In particular, as some transcrip-
tional factors are important for HIV-1 replication [36,37],
the study of their relation with SAMHD1 expression may
be of importance.
It is known that memory CD4þ T cells, the main targets
of HIV-1 [38], are heterogeneous in their susceptibility to
infection. Among the various subsets of CD4þ T cells,
Th17 cells are presumed to be the most susceptible to
HIV-1 infection and are preferentially depleted in
infected individuals [16–19,39]. We found that Th17
cells exhibit the lowest levels of SAMHD1 in HIV-
negative individuals. In addition, SAMHD1low Th17 cells
are preferentially decreased in HIV-infected individuals as
compared with controls, whereas SAMHD1þ Th17 cells
were not affected. Unlike for Th17 cells, we found lower
proportions of Th2 cells in both SAMHD1low and
SAMHD1þ compartments, in HIV-infected individuals
as compared with controls. These results suggest that the
low levels of Th2 cell are independent of SAMHD1
expression and are more likely the consequence of
antiviral immune responses. Our observation that
SAMHD1low Th17 cells were depleted in the blood of
HIV-infected individuals but preserved in elite controllers
brings to light a potential mechanistic link between loss of
Th17, lack of SAMHD1 and HIV-1 infection. These
results are in line with recent studies showing a role for
SAMHD1 in the permissiveness of CD4þ memory T
cells with stem cell-like properties (TSCM) to HIV-1
infection [40,41].
Lymphoid tissues are an important site for HIV-1
replication, with Tfh cells exhibiting the highest levels
of viral replication, and thus contributing to HIV
persistence [24,25]. In nontreated HIV-1-infected
SAMHD1 expression during HIV-1 infection Ruffin et al. 529individuals, despite high levels of viral replication, Tfh cell
numbers are increased and act as an important contributor
to the HIV-1 reservoir in vivo [24,25]. We demonstrate
here that lymph nodes CXCR5hiPD1hiBcl-6þ Tfh cells
lack SAMHD1 expression. Similar low expression of
SAMHD1 was found in tonsilar Tfh cells and was
associated with higher susceptibility toward HIV-1
infection. Indeed, non-Tfh CD4þ T-cell subsets that
displayed higher expression levels of SAMHD1 exhibited
lower HIV-1 infection. Of note, the discrepancies
between lymph nodes Tfh and peripheral Tfh-like cells
corroborate the interconnection between SAMHD1
levels and T-cell activation. Indeed, Tfh cells expressing
Bcl-6 are found in the germinal center, specialized
anatomic compartment of lymphoid tissues, and support
B cell differentiation into plasma cells and the generation
of potent antibody responses [28]. Tfh-like cells found in
periphery are thought to arise from the differentiation of
lymphoid Tfh into memory-like cells [42]. The Tfh-like
resting phenotype would thus coincide with a high
expression of SAMHD1. As Tfh functions are impaired
during HIV-1 infection [43], a better understanding of
molecular determinants leading to SAMHD1 modulation
in Tfh cells may provide important insights indispensable
for the generation of an efficient therapeutic vaccine.
Our work provides evidence that the lack of SAMHD1
expression plays an important role in the susceptibility of
differentiated memory CD4þ T-cell subsets to HIV-1
infection in vivo. The understanding of SAMHD1
expression and its modulation may open new avenues
for HIV research toward an HIV cure.Acknowledgements
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